A. L. Pousa

发表

Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up.

S. Sleijfer, E. Álava, E. Wardelmann, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

Corrections to "Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up".

S. Sleijfer, E. Wardelmann, S. Bonvalot, 2018 .

Head and Neck Sarcomas. Our Experience

A. L. Pousa, F. Sancho, Z. P. Aguín, 2011 .

OP-ANNO180096 51..67

S. Sleijfer, E. Álava, E. Wardelmann, 2018 .

Soft tissue and visceral sarcomas

S. Sleijfer, E. Álava, E. Wardelmann, 2022 .

Ten-Year Progression-Free and Overall Survival in Patients With Unresectable or Metastatic GI Stromal Tumors: Long-Term Analysis of the European Organisation for Research and Treatment of Cancer, Italian Sarcoma Group, and Australasian Gastrointestinal Trials Group Intergroup Phase III Randomized Tr

S. Sleijfer, J. Blay, S. Litière, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Circulating Tumor Cells and Biomarker Modulation with Olaratumab Monotherapy Followed by Olaratumab plus Doxorubicin: Phase Ib Study in Patients with Soft-Tissue Sarcoma

Robin L. Jones, J. Blay, B. V. Van Tine, 2020, Molecular Cancer Therapeutics.

Bone sarcomas: ESMO-PaedCan-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Robin L. Jones, S. Sleijfer, E. Álava, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

Pexidartinib Long‐Term Hepatic Safety Profile in Patients with Tenosynovial Giant Cell Tumors

W. Tap, J. Healey, H. Gelderblom, 2020, The Oncologist.

CLINICAL PRACTICE GUIDELINES Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up †

S. Sleijfer, E. Álava, E. Wardelmann, 2018 .

Primary, Non-metastatic Gastrointestinal Stromal Tumor Surgery: Results of the GRISK Study

A. L. Pousa, V. A. Raventós, L. O. Medina, 2013 .

Bone sarcomas: ESMO-EURACAN-GENTURIS-ERNPaedCan Clinical Practice Guideline for diagnosis, treatment and follow-up.

S. Sleijfer, S. Bonvalot, O. Mir, 2021, Annals of oncology : official journal of the European Society for Medical Oncology.

Randomized Phase II Study of Trabectedin and Doxorubicin Compared With Doxorubicin Alone as First-Line Treatment in Patients With Advanced Soft Tissue Sarcomas: A Spanish Group for Research on Sarcoma Study.

C. Balañà, J. Martín-Broto, J. Maurel, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

ead and Neck Sarcomas . Our Experience

A. L. Pousa, X. L. Vintró, J. G. Lorenzo, 2018 .

Adjuvant therapy in primary GIST: state-of-the-art.

J. Blay, J. Verweij, H. Joensuu, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

PCN6 PRIMARY PROPHYLAXIS WITH PEGFILGRASTIM IS COSTSAVING COMPARED WITH FILGRASTIM FOR BREAST CANCER IN SPAIN

A. L. Pousa, R. Dubois, R. Arocho, 2006 .

Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up.

S. Sleijfer, E. Wardelmann, S. Bonvalot, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial.

J. Blay, J. Coindre, P. Bruzzi, 2017, The Lancet. Oncology.

Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up.

P Reichardt, I Judson, Robin L. Jones, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

Gastrointestinal stromal tumours: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Robin L. Jones, S. Sleijfer, E. Álava, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

Gastrointestinal stromal tumours: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up.

S. Sleijfer, E. Wardelmann, S. Bonvalot, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

Corrections to "Gastrointestinal stromal tumours: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up".

S. Sleijfer, E. Wardelmann, S. Bonvalot, 2018 .

Dovitinib in patients with gastrointestinal stromal tumour refractory and/or intolerant to imatinib

J. Blay, H. Joensuu, A. Italiano, 2017, British Journal of Cancer.

Complete Longitudinal Analyses of the Randomized, Placebo-Controlled, Phase III Trial of Sunitinib in Patients with Gastrointestinal Stromal Tumor following Imatinib Failure

David Goldstein, Serge Leyvraz, Patrick Schöffski, 2012, Clinical Cancer Research.

Adjuvant therapy in primary GIST: state-of-the-art.

J. Blay, J. Verweij, A. Cesne, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

Bone sarcomas: ESMO-PaedCan-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up.

S. Sleijfer, E. Wardelmann, S. Bonvalot, 2018 .

Febrile neutropenia and related complications in breast cancer patients receiving pegfilgrastim primary prophylaxis versus current practice neutropaenia management: results from an integrated analysis.

M. Aapro, G. von Minckwitz, M. Schwenkglenks, 2009, European journal of cancer.

Gastrointestinal stromal tumours: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Robin L. Jones, S. Sleijfer, J. Blay, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

927P Initial results from a phase II study (TACTI-002) of eftilagimod alpha (soluble LAG-3 protein) and pembrolizumab as 2nd line treatment for PD-L1 unselected metastatic head and neck cancer patients

E. Felip, M. Forster, P. Roxburgh, 2020 .

Pexidartinib (Pex) for locally advanced tenosynovial giant cell tumour (TGCT): Characterization of hepatic adverse reactions (ARs)

W. Tap, J. Healey, H. Gelderblom, 2019, Annals of Oncology.

IMMUNOSARC: A collaborative Spanish (GEIS) and Italian (ISG) sarcoma groups phase I/II trial of sunitinib plus nivolumab in advanced soft tissue and bone sarcomas: Results of the phase II- soft-tissue sarcoma cohort

E. Álava, S. Stacchiotti, C. Valverde, 2019, Annals of Oncology.

LBA46PHASE 2 TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF DOVITINIB IN PATIENTS (PTS) WITH GASTROINTESTINAL STROMAL TUMOR (GIST) REFRACTORY AND/OR INTOLERANT TO IMATINIB (IM)

J. Blay, B. Bui, A. Cesne, 2014 .

A vision for inclusive and transparent health data in the beyond. Learning

M. Tattersall, I. Judson, B. Seddon, 2019 .

CLINICAL Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up † the ESMO Guidelines Committee and EURACAN*

E. Álava, A. Cesne, H. Joensuu, 2020 .